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ABSTRACT
Objectives: To evaluate the drug compliance level among the patients attending the outpatient department of Shri Sathya Sai Medical College Hospital 
using Morisky 8-item drug compliance questionnaire and to determine the factors which hinder them from adhering to physician’s prescription.
Methods: 100 patients who were on long-term drug treatment on outpatient basis were selected. Following that, Morisky 8-item drug compliance 
questionnaire, a self-reported scale of medication adherence was used. Along with the mentioned questions, a few questions to assess factors causing 
noncompliancy and their knowledge on drug compliance were included. Data were collected and based on the scale, the level of compliance, i.e., low, 
medium or high was estimated. Patients found noncompliant, factors hindering them from being noncompliant were assessed.
Results: Among the 100 patients, 33% belonged to low adherence group, 44% to medium adherence group, and 23% to high adherence group. 
Patients belonging to low and medium adherence group were segregated and their individual questionnaire was assessed and reason for being 
noncompliant analyzed. The majority of the low adherence group said that they discontinue treatment once they feel that their symptoms were under 
control.
Conclusion: Drug noncompliance is an important factor for treatment failure. The importance of medication adherence was re-emphasized to those 
patients who belonged to low/medium adherence group.
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INTRODUCTION
The term compliance describes the extent to which a person’s behavior 
coincides with medical advice. In drug therapy, compliance is defined 
as the degree of correspondence of the actual dosing history with the 
prescribed drug regimen [1].
Drug noncompliance is a growing concern to clinicians and health-care 
systems. Adherence rates are typically higher among patients with 
acute conditions, as compared with those with chronic conditions; 
persistence among patients with chronic conditions is disappointingly 
low, dropping most dramatically after the first 6 months of 
therapy [2-4].
Especially, the consequences of drug noncompliance may be serious in 
older patients. Some older patients who are acutely ill may take more 
than the prescribed dose of a medication in the mistaken belief that 
more of the drug will speed their recovery. Such overuse has clearly 
been associated with adverse drug effects. The use of at least three 
drugs, and often more, is common in the elderly, with estimates of as 
many as 25% of older people taking at least three drugs [5].
Numerous factors such as the duration of therapy, the complexity of 
the prescribed drug regimen and many psychosocial factors, alone 
or in combination, may contribute to variable compliance with drug 
therapy [6-7].
Hence, this study focussed on assessing the level of compliance to 
physician’s prescription and the factors which hinder them from 
adhering to the prescription.
AIMS AND OBJECTIVES
To evaluate the drug compliance level among the patients attending 
the outpatient department (OPD) of Shri Sathya Sai Medical College 
Hospital using Morisky 8-item drug compliance questionnaire and to 
determine the factors which hinder them from adhering to physician’s 
prescription.
METHODS
This study was carried out in Shri Sathya Sai medical college hospital 
and research institute after getting approval from the Institutional 
Ethical Committee.




Any adult patient attending the Medicine OPD of Shri Sathya Sai Medical 
College Hospital on a long-term treatment for chronic illness.
Exclusion criteria
Inpatients and patients treated for acute illness were excluded from the 
study.
Following that, Morisky 8-item drug compliance questionnaire, a self-
reported scale of medication adherence was used. All the questionnaire 
details were translated in the regional language. Data were collected, 
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and based on the scale, the level of compliance, i.e., low, medium or high 
was estimated. Patients found noncompliant, factors hindering them 
from being noncompliant were assessed. Descriptive statistics were 
applied for the study.
RESULTS
Fig. 1: Morisky 8-items medication adherence questionnaire
Fig. 2: Number of patients with the diseases
Fig.3: Based on Morisky questionnaire
•	 Of	 the	33	patients	belonging	 to	 the	 low	adherence	group,	all	 the	
patients said they sometimes forget to take the medicines.
•	 8	of	the	33	patients	said	that	they	stop	taking	the	medicines	once	




of them said that they sometimes forget to take their medicines. 
Moreover, 7 of them said that once they feel their symptoms are 
under control they stop taking the drugs.
DISCUSSION
This study was carried out in a tertiary care teaching hospital.
In a study by Jackevicius et al. on elderly patients on statin therapy, 
adherence rates were typically higher among patients with acute 
conditions, as compared with those with chronic conditions; persistence 
among patients with chronic conditions was disappointingly low, 
dropping most dramatically after the first 6 months of therapy [2-4].
In responses to a questionnaire study by Cramer, typical reasons cited 
by patients for not taking their medications included forgetfulness 
(30%), other priorities (16%), decision to omit doses (11%), lack of 
information (9%), and emotional factors (7%); 27% of the respondents 
did not provide a reason for poor adherence to a regimen [8].
Physicians contribute to patients’ poor adherence by prescribing 
complex regimens, failing to explain the benefits and side effects of 
a medication adequately, not giving consideration to the patient’s 
lifestyle or the cost of the medications, and having poor therapeutic 
relationships with their patients [9-12].
In a study by Venkateswararao et al., which included 60 chronic renal 
failure patients on hemodialysis with an objective to evaluate the degree 
of adherence, perception toward various treatment recommendations 
and the effect of pharmacist’s intervention in improving compliance 
among patients on hemodialysis, the Common reason cited by study 
subjects for noncompliance to medications was forgetfulness [13].
In a study by Ai Sim Wee et al., a total of 51 rheumatoid arthritis (RA) 
patients using DMARD were recruited and a researcher-assisted 
questionnaires were utilized to assess the adherence using compliance 
questionnaire on rheumatology and found that the necessity-concerns 
differential of medication beliefs may serve as a possible screening 
tool for nonadherence or target for adherence-improving intervention 
among RA patients [14].
In our study, we had 77% of the patients said that they sometimes forget 
to take their medicines. Common barriers to adherence are under the 
patient’s control so that attention to them is a necessary and important 
step in improving adherence.
The concerned treating physicians were informed regarding the 
noncompliancy of drugs. Methods that can be used to improve 
adherence can be grouped into three general categories: Patient 
education, improved dosing schedules, and improved communication 
between physicians and patients.
CONCLUSION
Various considerations have to be taken while prescribing regimens for 
better drug compliance from the patient side. This study was carried 
out in a rural set up, of which 33% low adherence was noted. The 
importance of taking drugs regularly has to be re-emphasized for the 
benefit of the patient. A study in a huge sample size would be required 
in future for better assessment.
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